Searched for
CEO VIVEK TIWARI
More big four pros landing at C-suite spot as firms become leadership pipelineThe Big Four accounting firms—EY, PwC, KPMG, and Deloitte—are increasingly becoming a significant source of C-suite talent for corporations...
PhysicsWallah’s acquisition talks with Drishti IAS falls through; Drishti to continue as an independent companyDiscussions for PhysicsWallah's acquisition of Drishti IAS, a prominent UPSC test preparation platform, have concluded without a deal. Dris...
Smaller towns & state boards: How the bet to go vernacular paid off for Drishti IASDrishti IAS, founded in 1999, prioritises Hindi-medium students in civil services preparation, achieving Rs 405 crore revenue in FY24. At a...
BluSmart bust makes investors rewrite the fine printFollowing financial irregularities at Gensol Engineering and BluSmart, investors are tightening investment contract terms. Lawyers indicate...
Consumer companies now have a new fix: MNC-fied CEOsMany top consumer companies in India, like Avenue Supermarts (DMart), Tata Consumer Products, and Nestle India, are appointing new CEOs wit...
Medikabazaar appoints Dinesh Lodha as new CEO amid leadership changesDinesh Lodha comes in place of Vivek Tiwari, the company’s cofounder who stepped down from the CEO’s position in the backdrop of the compan...
Top startup and tech stories this weekETtech Unwrapped is packed with the most important stories that we covered this week. Here’s a quick recap.
ETtech Exclusive: Medtech firm Medikabazaar rejigs top deck; PwC audit spots issuesMedikabazaar undergoes management reshuffle with CEO stepping down amid financial discrepancies. Investors demand audits and CEO transition...
Medikabazaar looks to raise up to $200 mn for expansionIf the proposed fundraise materialises, Medikabazaar will possibly enter unicorn club, or $1-billion valuation. Medikabazaar in April 2022 ...
B2B health-tech startup Medikabazaar ropes in new CHRO and COOThe move will aim to strengthen its leadership in the healthcare supply chain, grow in the emerging market segment, aid in institutional li...
Exclusive: Medikabazaar raises $65 million in funding led by Lighthouse India FundLighthouse, an investor in Nykaa, Bikaji Foods and Duroflex, has brought in $30 million, with the rest coming from existing investors such ...
Medikabazaar gets $75 million funding from Creaegis, CDC Group, othersThe company will use the funds to strengthen its digital capabilities, deepen the supply ecosystem and technology driven distribution chann...
Microfinance player urges govt to curb rumours about loan waivers amid COVID-19New Delhi, Sep 6 () A microfinance player on Sunday charged that some fraudulent elements are spreading rumours about loan waivers amid the...
Satya MicroCapital, Sindhuja Microcredit raise Rs 170 crore from global investorsSatya MicroCapital started its operations in January 2017 and has a network of 150 branches in 22 states. It primarily caters to women who ...
MedikaBazaar CEO feels maintaining mind & body crucial for work-life balanceVivek Tiwari is looking forward to going back to work to meet his 'other family'.
Coronavirus terror in India: Sanitisers, masks sold out, prices peakAs Covid-19 patients continue to rise in India, some retailers and mask manufacturers are cashing in on the virus terror by jacking up pric...
Medikabazaar gets Rs 112 crore in Series BThe startup will use the proceeds to build on its technology suite, supply chain infrastructure and for augmenting its team, as per a senio...
Satya MicroCapital collects Rs 100 crore through cashless transactions18% was collected by the MFI in the first year of its operations, 40% in the second year and 42% during the first half of 2019.
Satya MicroCapital reaches over 2.25 lakh entrepreneursKeeping up with the post-demonetisation tide, the company’s focus on lending using digital financial solutions to women entrepreneurs speci...
How NBFC-MFIs can ensure equitable distribution of credit across MSMEsMSME manufacturing units often end up being overlooked by formal banks and financial companies which usually favour big-ticket borrowers.